- Factor XI - Wikipedia, the free encyclopedia
The zymogen factor is activated into factor XIa by factor XIIa (FXIIa), thrombin, and it is also autocatalytic, and FXI is a member of the "contact pathway" due to ...
- Novel 3-carboxamide-coumarins as potent and selective FXIIa ...
1. J Med Chem. 2008 Jun 12;51(11):3077-80. Epub 2008 May 7. Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors. Robert S, Bertolla C, Masereel B ...
- Epidemiological and Genetic Associations of Activated Factor XII ...
Background—The relations of plasma activated factor XII (FXIIa) concentration and a common polymorphism (C46T) of ...
- Competitive-Protein Adsorption in Contact Activation of Blood ...
Partitioning establishes the interphase concentrations FXII·S and FXIIa·S that ultimately control rate and yield of FXIIa production in solution.
- ADI (American Diagnostica Inc.) creating products for life®
ADI (American Diagnostica Inc.) is a company that develops and manufactures products for medical diagnostics, coagulation and hematology, medical research, and the ...
- Chromogenic Substrates | Methods | Prekallikrein
Contact activation: FXIIa: Prekallikrein: FXIIa + HMW kininogen: Kallikrein: H-D-Pro-Phe-Arg-pNA + H2O: Kallikrein: H-D-Pro-Phe-Arg-OH + pNA
- Extrinsic Coagulation Factors and Tissue Factor Pathway Inhibitor ...
The relationship between extrinsic coagulation factors, tissue factor pathway inhibitor (TFPI) and activated factor XII (FXIIa) was examined in 71 patients with end ...
- Local Bradykinin Formation Is Controlled by Glycosaminoglycans
These surfaces induce autoactivation of the zymogen, FXII, to the active enzyme (FXIIa) that in turn converts HK-bound PK to its active form ...
- Coagulation factor XII (FXII) activity, activated FXII ...
FXIIa was significantly reduced in the ACS group only , but the significant association disappeared in the multivariate model (P = 0.83). The correlation between FXII ...
- Lower factor XII activity is a risk marker rather than a risk ...
Therefore, a high level of FXIIa has been proposed to be a biomarker for atherosclerotic vascular damage, although this remains controversial . Previous studies have ...